Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medical composition for facilitating repair of hematopoietic damage

A technology of hematopoietic injury and composition, which is applied in the medical field and can solve the problems of fast recovery of white blood cell count and other problems

Inactive Publication Date: 2015-08-26
EAST CHINA UNIV OF SCI & TECH
View PDF3 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Liu Changsheng and others found that rhBMP-2 fusion protein has an effective therapeutic effect on hematopoietic injury caused by radiotherapy and chemotherapy, but the recovery speed of its white blood cell count is not as fast as that of granulocyte colony-stimulating factor

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medical composition for facilitating repair of hematopoietic damage
  • Medical composition for facilitating repair of hematopoietic damage
  • Medical composition for facilitating repair of hematopoietic damage

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0081] Synergistic effect of recombinant human bone morphogenetic protein-2 (rhBMP-2) and granulocyte-stimulating factor (G-CSF) in the repair of hematopoietic injury induced by radiotherapy drugs

[0082] The purpose of this example is to observe the synergistic effect of rhBMP-2 and G-CSF on the therapeutic recovery of peripheral blood leukocytes, erythrocytes, hemoglobin, and thrombocytopenia caused by chemotherapy drugs, so as to find a clinically fast and stable Improve the new system of therapeutic drugs against chemotherapy damage.

[0083] Material

[0084] Recombinant human bone morphogenetic protein-2: rhBMP-2 (refer to CN200910045832 preparation, SEQ ID NO: 2);

[0085] Granulocyte-stimulating factor: rhG-CSF, commercialized recombinant human granulocyte-stimulating factor injection (trade name: Jilifen)

[0086] method

[0087] SPF grade C57BL / 6 mice, male, 6-8 weeks old, 18-20 g, were randomly divided into 20 mice in each group.

[0088] The experimental group...

Embodiment 2

[0120] Synergistic effect of recombinant human bone morphogenetic protein (rhBMP-2) and granulocyte-stimulating factor (G-CSF) in the repair of hematopoietic damage induced by radiation therapy

[0121] The purpose of this example is to observe the synergistic effect of rhBMP-2 and G-CSF on the therapeutic recovery of red blood cells, hemoglobin, and thrombocytopenia caused by radiotherapy rays.

[0122] Material

[0123] Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2)

[0124] Granulocyte-stimulating factor: commercialized recombinant human granulocyte-stimulating factor injection (trade name Jirifen)

[0125] method

[0126] SPF grade C57BL / 6 mice, male, 6-8 weeks old, 18-20 g, were randomly divided into 20 mice in each group.

[0127] The experimental groups are as follows:

[0128] Except for the normal control group, mice in each group were irradiated with X-rays all over the body at one time, with a total dose of 6.0Gy, a dose rate of 1.09Gy / min, and an irra...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medical composition for facilitating repair of hematopoietic damage. The medical composition comprises recombinant human bone morphogenetic protein-2 and human granulocyte stimulating factors, through the favorable synergistic reaction of the recombinant human bone morphogenetic protein-2 and the human granulocyte stimulating factors, recovery of hematopoietic stem cells, functional cells of a spleen and functional cells of a thymus during the hematopoietic damage can be effectively facilitated, the recovery of blood cells of peripheral blood when a hematopoietic function is poor can also be facilitated, the recovery of white blood cells of the peripheral blood during bone marrow transplantation can be accelerated, and the medical composition can be used as a medicine for preventing and / or treating the hematopoietic damage and a mobilizing agent for transplantation of stem cells of the peripheral blood.

Description

technical field [0001] The present invention relates to the field of medicine, in particular to a pharmaceutical composition for promoting the repair of hematopoietic damage, in particular to a composition comprising recombinant human bone morphogenetic protein-2 (bone morphogenetic protein, rhBMP-2) and human granulocyte-stimulating factor (rhG-CSF) The composition is used for promoting the repair of hematopoietic damage. Background technique [0002] In recent years, the incidence of malignant tumors, acute radiation sickness and various blood diseases caused by environmental pollution, chemical pollution, ionizing radiation and other factors has been increasing worldwide. At present, radiotherapy and chemotherapy are mainly used to treat tumors. Bone marrow suppression is one of the most common side effects of radiotherapy and chemotherapy. However, when the body is irradiated with lethal doses of radiation or receives a considerable dose of chemotherapy drugs, it will le...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/19A61P7/00A61K38/17
Inventor 刘昌胜高巧艳王靖戴凯龙丹丹
Owner EAST CHINA UNIV OF SCI & TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com